Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 6: Vaccines for Enteric Diseases (ENTERIC SI)
Submit an article Journal homepage
971
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

In vitro characterization and preclinical immunogenicity of Typhax, a typhoid fever protein capsular matrix vaccine candidate

Thomas J. Griffin IVa Matrivax Research & Development Corporation, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0002-2814-4183
ORCID Icon,
Ann Thanawastiena Matrivax Research & Development Corporation, Boston, MA, USA
,
Robert T. Carteea Matrivax Research & Development Corporation, Boston, MA, USA
,
John J. Mekalanosb Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA
&
Kevin P. Killeena Matrivax Research & Development Corporation, Boston, MA, USACorrespondence[email protected]
Pages 1310-1316 | Received 07 Dec 2018, Accepted 17 Mar 2019, Published online: 28 May 2019

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dani Cohen & Khitam Muhsen. (2019) Vaccines for enteric diseases. Human Vaccines & Immunotherapeutics 15:6, pages 1205-1214.
Read now

Articles from other publishers (3)

Yoshikazu Honda-Okubo, Robert T. Cartee, Ann Thanawastien, Jae Seung Yang, Kevin P. Killeen & Nikolai Petrovsky. (2022) A typhoid fever protein capsular matrix vaccine candidate formulated with Advax-CpG adjuvant induces a robust and durable anti-typhoid Vi polysaccharide antibody response in mice, rabbits and nonhuman primates. Vaccine 40:32, pages 4625-4634.
Crossref
M. V. Abramtseva, E. O. Nemanova, N. S. Alekhina & T. I. Nemirovskaya. (2021) Typhoid vaccines. Historical aspects of typhoid vaccine development, and currently available products. BIOpreparations. Prevention, Diagnosis, Treatment 21:2, pages 85-96.
Crossref
Robert T. Cartee, Ann Thanawastien, Thomas J. Griffin IV, John J. Mekalanos, Stephan Bart & Kevin P. Killeen. (2020) A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of typhoid fever. PLOS Neglected Tropical Diseases 14:1, pages e0007912.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.